Published articles & abstracts Archive

Novel small molecule decreases cell proliferation, migration, clone formation, and gene expression through ERK inhibition in MCF-7 and MDA-MB-231 breast cancer cell lines

Published: 6 February 2019

Link: https://www.ncbi.nlm.nih.gov/pubmed/30741723

Authors: Hatzidaki E, Parsonidis P, Apostolou P, Daikopoulou V, Papasotiriou I.

Folic Acid-Functionalized Gold Nanorods for Controlled Paclitaxel Delivery: In Vitro Evaluation and Cell Studies

Published: 1 December 2018

Link: https://www.ncbi.nlm.nih.gov/pubmed/30560417

Authors: Papaioannou L, Angelopoulou A, Hatziantoniou S, Papadimitriou M, Apostolou P, Papasotiriou I, Avgoustakis K.

Read article

The use of serum extracellular vesicles for novel small molecule inhibitor cell delivery

Published: 26 November 2018

Link: https://www.ncbi.nlm.nih.gov/pubmed/30489291

Authors: Hatzidaki E, Vlachou I, Elka A, Georgiou E, Papadimitriou M, Iliopoulos A, Papasotiriou I.

Read article

Risk prediction of metastasis through study of circulating tumor cells

Published: 19 October 2018

Document: Risk prediction of metastasis through study of circulating tumor cells

Authors: Apostolou P., Papasotiriou I.

Read article

Retrotransposons in circulating free DNA from cancer patients

Published: 28 September 2018

Document: Retrotransposons in circulating free DNA from cancer patients

Authors: Apostolou P., Parsonidis P., Papasotiriou I.

Read article

CD163 detection in breast cancer patients’ peripheral blood. A possible marker?

Published: 1 September 2018

Document: CD163 detection in breast cancer patients’ peripheral blood. A possible marker?

Authors: Ntanovasilis D.A., Papasotiriou I.

Read article

Quantitative Nuclear Magnetic Resonance for the determination of Genistein in capsules

Published: 1 July 2018

Document: Quantitative Nuclear Magnetic Resonance for the determination of Genistein in capsules

Authors: Vlachou I, Papasotiriou I.

Read article

CTCs enumeration and profile in different cancer types in a group of patients from United States

Published: 1 June 2018

Link: https://meetinglibrary.asco.org/record/164585/abstract

Authors: Ioannis Papasotiriou, Dimitrios Ntanovasilis, Panagiotis Apostolou

Read article

Molecular profiling of gastrointestinal cancer

Published: 1 June 2018

Document: Molecular profiling of gastrointestinal cancer

Authors: Apostolou P, Papadimitriou M, Parsonidis P, Iliopoulos A.C, Papasotiriou I.

Read article

Isolation and characterization of CTCs from breast cancer patients with and without metastasis

Published: 1 May 2018

Document: Isolation and characterization of CTCs from breast cancer patients with and without metastasis

Authors: Ntanovasilis D.A, Apostolou P, Papadimitriou M. Papasotiriou I.

Read article

EV-encapsulated small molecule inhibitor decreases viability in cancer cell lines

Published: 1 May 2018

Document: EV-encapsulated small molecule inhibitor decreases viability in cancer cell lines

Authors: Eleana Hatzidaki, Ioanna Vlachou, Maria Papadimitriou, Ioannis Papasotiriou

Read article

Flow cytometric analysis of CTCs in breast cancer patients before and after chemotherapy

Published: 1 April 2018

Document: Flow cytometric analysis of CTCs in breast cancer patients before and after chemotherapy

Authors: Ntanovasilis D.A., Papasotiriou I.

Read article

Published articles & abstracts

Novel small molecule decreases cell proliferation, migration, clone formation, and gene expression through ERK inhibition in MCF-7 and MDA-MB-231 breast cancer cell lines

Folic Acid-Functionalized Gold Nanorods for Controlled Paclitaxel Delivery: In Vitro Evaluation and Cell Studies

The use of serum extracellular vesicles for novel small molecule inhibitor cell delivery

Risk prediction of metastasis through study of circulating tumor cells

Retrotransposons in circulating free DNA from cancer patients

CD163 detection in breast cancer patients’ peripheral blood. A possible marker?

Quantitative Nuclear Magnetic Resonance for the determination of Genistein in capsules

CTCs enumeration and profile in different cancer types in a group of patients from United States

Molecular profiling of gastrointestinal cancer

Isolation and characterization of CTCs from breast cancer patients with and without metastasis

EV-encapsulated small molecule inhibitor decreases viability in cancer cell lines

Flow cytometric analysis of CTCs in breast cancer patients before and after chemotherapy

Need help?

Will you send me the results directly?

Do I need to go through my GP to get a test?

Can RGCC test for BRAF drugs?

Can the Oncotrace test differentiate between benign and malignant tumour cells?

I have a patient whose specific tumour appears to have resisting populations because of the overexpression of the MDR1 gene. This can be reversed by the use of inhibitors of ABG2 pumps. What do I do?

Global Presence

Novel small molecule decreases cell proliferation, migration, clone formation, and gene expression through ERK inhibition in MCF-7 and MDA-MB-231 breast cancer cell lines

Folic Acid-Functionalized Gold Nanorods for Controlled Paclitaxel Delivery: In Vitro Evaluation and Cell Studies

The use of serum extracellular vesicles for novel small molecule inhibitor cell delivery

Risk prediction of metastasis through study of circulating tumor cells

Retrotransposons in circulating free DNA from cancer patients

CD163 detection in breast cancer patients’ peripheral blood. A possible marker?

Quantitative Nuclear Magnetic Resonance for the determination of Genistein in capsules

CTCs enumeration and profile in different cancer types in a group of patients from United States

Molecular profiling of gastrointestinal cancer

Isolation and characterization of CTCs from breast cancer patients with and without metastasis

EV-encapsulated small molecule inhibitor decreases viability in cancer cell lines

Flow cytometric analysis of CTCs in breast cancer patients before and after chemotherapy

Need help?

Will you send me the results directly?

Do I need to go through my GP to get a test?

Can RGCC test for BRAF drugs?

Can the Oncotrace test differentiate between benign and malignant tumour cells?

I have a patient whose specific tumour appears to have resisting populations because of the overexpression of the MDR1 gene. This can be reversed by the use of inhibitors of ABG2 pumps. What do I do?

Global Presence

Cookies